Apremilast is a potentially useful treatment for severe palmoplantar pustulosis with extra-palmoplantar symptoms

Ayano Fukushima-Nomura, Saeko Takamiyagi, Risa Kakuta, Yoshihiro Ito, Ikuko Hirai, Junichi Umemoto, Hironari Hanaoka, Yuko Kaneko, Keiji Tanese

研究成果: Article査読

抄録

Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disorder affecting the palms and soles. In rare cases, severe patients develop acute extra-palmoplantar lesions often accompanied by arthralgia. Such cases with extensive symptoms often necessitate systemic treatments with variable efficacy and potential side effects. Apremilast, known for its broad immune response modulation, presents promise as a therapeutic option for severe PPP with joint and extra-palmoplantar lesions. This case highlights apremilast as a potential systemic treatment for such cases with minimal side effects.

本文言語English
論文番号e336
ジャーナルSkin Health and Disease
4
2
DOI
出版ステータスPublished - 2024 4月

ASJC Scopus subject areas

  • 皮膚病学

フィンガープリント

「Apremilast is a potentially useful treatment for severe palmoplantar pustulosis with extra-palmoplantar symptoms」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル